E2f binding-deficient Rb1 protein suppresses prostate tumor progression in vivo

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 2, 2011, Pages 704-709

  Sun, Huifang ^a,d   Wang, Yanqing ^a   Chinnam, Meenalakshmi ^a   Zhang, Xiaojing ^a   Hayward, Simon W ^b   Foster, Barbara A ^a   Nikitin, Alexander Y ^c   Wills, Marcia ^b,e   Goodrich, David W ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c Department of Obstetrics Gynecology   (United States)

^d WESTERN KENTUCKY UNIVERSITY   (United States)

^e Seacoast Pathology   (United States)

Author keywords

Cellular senescence; Mouse model; Retinoblastoma gene

Indexed keywords

PROTEIN RB1; TRANSCRIPTION FACTOR E2F; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CARCINOGENESIS; CELL AGING; CONTROLLED STUDY; EMBRYO; IN VIVO STUDY; MOUSE; MUTANT; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION;

ALLELES; ANIMALS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DNA MUTATIONAL ANALYSIS; E2F TRANSCRIPTION FACTORS; GENES, RETINOBLASTOMA; HETEROZYGOTE; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PROSTATIC NEOPLASMS; RETINOBLASTOMA PROTEIN;

MUS;

EID: 79551675502     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1015027108     Document Type: Article

References (40)

1. Burkhart DL, Sage J (2008) Cellular mechanisms of tumour suppression by the retinoblastoma gene. Nat Rev Cancer 8:671-682.
2. Pacal M, Bremner R (2006) Insights from animal models on the origins and progression of retinoblastoma. Curr Mol Med 6:759-781.
3. Walkley CR, et al. (2008) Conditional mouse osteosarcoma, dependent on p53 loss and potentiated by loss of Rb, mimics the human disease. Genes Dev 22:1662-1676.
4. Meuwissen R, et al. (2003) Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model. Cancer Cell 4:181-189.
5. Simin K, et al. (2004) pRb inactivation in mammary cells reveals common mechanisms for tumor initiation and progression in divergent epithelia. PLoS Biol 2:E22.
6. Flesken-Nikitin A, Choi KC, Eng JP, Shmidt EN, Nikitin AY (2003) Induction of carcinogenesis by concurrent inactivation of p53 and Rb1 in the mouse ovarian surface epithelium. Cancer Res 63:3459-3463. (Pubitemid 36793020)
7. Zhou Z, et al. (2006) Synergy of p53 and Rb deficiency in a conditional mouse model for metastatic prostate cancer. Cancer Res 66:7889-7898.
8. Hill R, Song Y, Cardiff RD, Van Dyke T (2005) Heterogeneous tumor evolution initiated by loss of pRb function in a preclinical prostate cancer model. Cancer Res 65: 10243-10254.
9. van den Heuvel S, Dyson NJ (2008) Conserved functions of the pRB and E2F families. Nat Rev Mol Cell Biol 9:713-724.
10. Hallstrom TC, Nevins JR, Hallstrom TC, Nevins JR (2009) Balancing the decision of cell proliferation and cell fate. Cell Cycle 8:532-535.
11. Frolov MV, Dyson NJ (2004) Molecular mechanisms of E2F-dependent activation and pRB-mediated repression. J Cell Sci 117:2173-2181. (Pubitemid 38807486)
12. DeGregori J, Johnson DG, DeGregori J, Johnson DG (2006) Distinct and overlapping roles for E2F family members in transcription, proliferation and apoptosis. Curr Mol Med 6:739-748.
13. Wu L, et al. (2001) The E2F1-3 transcription factors are essential for cellular proliferation. Nature 414:457-462.
14. Bettendorf O, et al. (2008) Chromosomal imbalances, loss of heterozygosity, and immunohistochemical expression of TP53, RB1, and PTEN in intraductal cancer, intraepithelial neoplasia, and invasive adenocarcinoma of the prostate. Genes Chromosomes Cancer 47:565-572.
15. Jarrard DF, et al. (2002) Alterations in the p16/pRb cell cycle checkpoint occur commonly in primary and metastatic human prostate cancer. Cancer Lett 185: 191-199.
16. Mack PC, et al. (1998) Increased RB1 abnormalities in human primary prostate cancer following combined androgen blockade. Prostate 34:145-151.
17. Tricoli JV, et al. (1996) Alterations of the retinoblastoma gene in human prostate adenocarcinoma. Genes Chromosomes Cancer 15:108-114. (Pubitemid 26048411)
18. Sun H, et al. (2006) An E2F binding-deficient Rb1 protein partially rescues developmental defects associated with Rb1 nullizygosity. Mol Cell Biol 26:1527-1537.
19. Lee JO, Russo AA, Pavletich NP (1998) Structure of the retinoblastoma tumour-suppressor pocket domain bound to a peptide from HPV E7. Nature 391:859-865.
20. Ji P, et al. (2004) An Rb-Skp2-p27 pathway mediates acute cell cycle inhibition by Rb and is retained in a partial-penetrance Rb mutant. Mol Cell 16:47-58.
21. Sellers WR, et al. (1998) Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth. Genes Dev 12:95-106.
22. Harbour JW (2001) Molecular basis of low-penetrance retinoblastoma. Arch Ophthalmol 119:1699-1704.
23. Jacks T, et al. (1992) Effects of an Rb mutation in the mouse. Nature 359:295-300.
24. Zhou Z, et al. (2005) Suppression of melanotroph carcinogenesis leads to accelerated progression of pituitary anterior lobe tumors and medullary thyroid carcinomas in Rb+/- mice. Cancer Res 65:787-796.
25. Hu N, et al. (1994) Heterozygous Rb-1 delta 20/+ mice are predisposed to tumors of the pituitary gland with a nearly complete penetrance. Oncogene 9:1021-1027. (Pubitemid 24095009)
26. Matoso A, Zhou Z, Hayama R, Flesken-Nikitin A, Nikitin AY (2008) Cell lineage-specific interactions between Men1 and Rb in neuroendocrine neoplasia. Carcinogenesis 29: 620-628.
27. Yamasaki L, et al. (1998) Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(+/-)mice. Nat Genet 18:360-364.
28. Day KC, et al. (2002) Rescue of embryonic epithelium reveals that the homozygous deletion of the retinoblastoma gene confers growth factor independence and immortality but does not influence epithelial differentiation or tissue morphogenesis. J Biol Chem 277:44475-44484.
29. Wang Y, et al. (2000) Sex hormone-induced carcinogenesis in Rb-deficient prostate tissue. Cancer Res 60:6008-6017.
30. Zhou Z, Flesken-Nikitin A, Nikitin AY (2007) Prostate cancer associated with p53 and Rb deficiency arises from the stem/progenitor cell-enriched proximal region of prostatic ducts. Cancer Res 67:5683-5690. (Pubitemid 46985000)
31. Wu X, et al. (2001) Generation of a prostate epithelial cell-specific Cre transgenic mouse model for tissue-specific gene ablation. Mech Dev 101:61-69.
32. Bracken AP, Ciro M, Cocito A, Helin K (2004) E2F target genes: Unraveling the biology. Trends Biochem Sci 29:409-417.
33. Chicas A, et al. (2010) Dissecting the unique role of the retinoblastoma tumor suppressor during cellular senescence. Cancer Cell 17:376-387.
34. Weinberg RA (1995) The retinoblastoma protein and cell cycle control. Cell 81: 323-330.
35. Lazzerini Denchi E, Attwooll C, Pasini D, Helin K (2005) Deregulated E2F activity induces hyperplasia and senescence-like features in the mouse pituitary gland. Mol Cell Biol 25:2660-2672.
36. Courtois-Cox S, Jones SL, Cichowski K (2008) Many roads lead to oncogene-induced senescence. Oncogene 27:2801-2809.
37. Narita M, et al. (2003) Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 113:703-716.
38. Haslam SZ, Levely ML (1985) Estrogen responsiveness of normal mouse mammary cells in primary cell culture: Association of mammary fibroblasts with estrogenic regulation of progesterone receptors. Endocrinology 116:1835-1844.
39. Wang X, et al. (2009) Thoc1 deficiency compromises gene expression necessary for normal testis development in the mouse. Mol Cell Biol 29:2794-2803.
40. Li Y, et al. (2007) Cancer cells and normal cells differ in their requirements for Thoc1. Cancer Res 67:6657-6664.